Minimed Group, Inc.
MMED
$12.34
$0.322.66%
NASDAQ
| 01/23/2026 | 10/24/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.12% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.12% | 0.00% | |||
| Cost of Revenue | 32.50% | 0.00% | |||
| Gross Profit | -12.17% | 0.00% | |||
| SG&A Expenses | 7.48% | 0.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 814.29% | 0.00% | |||
| Total Operating Expenses | 20.55% | 0.00% | |||
| Operating Income | -970.00% | 0.00% | |||
| Income Before Tax | -10,000.00% | 0.00% | |||
| Income Tax Expenses | 4.35% | 0.00% | |||
| Earnings from Continuing Operations | -957.14% | 0.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -100.00% | 0.00% | |||
| Net Income | -720.69% | 0.00% | |||
| EBIT | -970.00% | 0.00% | |||
| EBITDA | -197.96% | 0.00% | |||
| EPS Basic | -1,088.64% | 0.00% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -1,088.64% | 0.00% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||